Nausea and vomiting after shoulder arthroscopic surgery
Conditions
Interventions
Experimental group:Oxeridine injection
Control group:Sufentanil injection
Sponsors
Hebei Province Cangzhou Hospital of integrated Traditional Chinese and Western Medicine,Cangzhou,Hebei,China
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Patient or family member signs the informed consent form; 2. Planning to schedule a beach chair position shoulder arthroscopy, postoperatively will need to use patient-controlled intravenous analgesia; 3. Age 18-65 years; 4. No gender restriction; 5. American Society of Anesthesiologists (ASA) classification I~III.
Exclusion criteria
Exclusion criteria: 1. Pregnant patients; 2. Severe cardiac dysfunction (NYHA class IV), abnormal liver function (Child-Pugh class C, Appendix 1), severe renal dysfunction (preoperative dialysis), or ASA classification >= IV; 3. Severe organ (heart, lung, liver, kidney) dysfunction, neurological disorders; severe arrhythmias; 4. Unable to understand the visual analog scale or having language communication barriers; 5. Other conditions deemed unsuitable for study participation by the researcher or attending physician.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The incidence of PONV within 48 hours after surgery; | — |
Secondary
| Measure | Time frame |
|---|---|
| Resting and active pain NRS score;The number of effective compressions, total compressions, drug consumption (µg/kg), rate of relief analgesia demand and drug dosage of the analgesic pump;Ramsay calm score; | — |
Countries
China
Contacts
Public ContactKangzhuangzhuang
Hebei Province Cangzhou Hospital of integrated Traditional Chinese and Western Medicine,Cangzhou,Hebei,China
Outcome results
None listed